A new report by Transparency Market Research provides in-depth analysis of the global interventional oncology market. Expansion of the global interventional oncology market can be attributed to rise in prevalence of cancer worldwide and increase in demand for minimally invasive procedures.
๐๐๐ญ ๐ฒ๐จ๐ฎ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ญ๐จ ๐๐จ๐จ๐ฌ๐ญ ๐๐จ๐ฎ๐ซ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐ง๐จ๐ฐ๐ฅ๐๐๐ ๐ ๐๐จ๐ซ ๐๐๐ฅ๐ฎ๐๐๐ฅ๐ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=60477
Interventional oncology is a branch of medical science that deals with minimally invasive medical procedures carried out under image guidance by interventional radiologists for the diagnosis, treatment, and palliation of different types of cancer. These procedures offer advantages such as quicker recovery, shorter hospital stays, minimal side-effects, and more precise and accurate treatment as compared to other therapeutic procedures.
Embolization procedure segment to dominate global market
Based on procedure, the global interventional oncology market has been classified into ablation procedure, embolization procedure, and radiotherapy procedure. The embolization procedure segment dominated the global interventional oncology market in 2020. Embolization is a process involving lodging of embolus within the bloodstream in order to block the blood supply to the tumor. The process involves chemical or irradiation technique for selective occlusion of blood vessels by introducing emboli.
North America to lead global market growth
Geographically, the global interventional oncology market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global interventional oncology market in 2020. High prevalence of cancer, presence of key players, and early adoption of technologically advanced products drive the interventional oncology market in the region. However, the market in Asia Pacific is expected to expand at a high CAGR during the forecast period.
Key players operating in the global interventional oncology market include Boston Scientific Corporation, Medtronic plc, Terumo Corporation, BTG plc., AngioDynamics, Inc., Ethicon, Inc. (Johnson & Johnson), Merit Medical Systems, Inc., Sirtex Medical Limited, Siemens Healthineers, Eckert & Ziegler BEBIG, and Varian Medical Systems, Inc. among others. Major players adopt strategies such as mergers, acquisitions, partnerships, and new product launches to expand their product portfolio and strengthen their geographic presence.
The study is a compilation of primary and secondary research conducted by analysts at Transparency Market Research to provide reliable insights to stakeholders, product manufacturers, and the value chain. The report aims to provide comprehensive information on the current market scenario and future growth prospects.
๐๐๐จ๐ฎ๐ญ ๐๐ฌ ๐๐ซ๐๐ง๐ฌ๐ฉ๐๐ซ๐๐ง๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐ฌ
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA โ Canada Toll Free: 866-552-3453